Ocular Hypertension
📧 Sign up to get email alerts when something new happens for Ocular Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-03-30Clinical Trial Update: Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension [Phase 1, Phase 2]
Phase 1/2 trial update on a new ophthalmic formulation of bimatoprost for open-angle glaucoma and ocular hypertension; results have been pos…
-
CLINICAL_TRIALS trial_result · 2019-12-09Clinical Trial Update: Non-inferiority of PRO-122 Ophthalmic Solution vs KRYTANTEK Ofteno® in Glaucoma or Ocular Hypertension (CONFORTK) [Phase 3]
Phase 3 trial reporting non-inferiority of PRO-122 ophthalmic solution compared to KRYTANTEK Ofteno in primary open-angle glaucoma and ocula…
-
CLINICAL_TRIALS trial_result · 2019-11-15Clinical Trial Update: Study of Netarsudil Ophthalmic Solution in Japanese/Japanese-American Subjects With Open-angle Glaucoma or Ocular Hypertension [Phase 2]
Phase 2 trial of netarsudil ophthalmic solution in Japanese and Japanese-American subjects with open-angle glaucoma or ocular hypertension c…
-
CLINICAL_TRIALS trial_result · 2019-10-28Clinical Trial Update: Non-inferiority of PRO-067 Ophthalmic Solution vs GAAP Ofteno® in Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 non-inferiority trial comparing PRO-067 ophthalmic solution to Ofteno in primary open-angle glaucoma and ocular hypertension was ter…
-
CLINICAL_TRIALS trial_result · 2019-10-17Clinical Trial Update: Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma [Phase 2]
Phase 2 trial assessing safety and efficacy of ENV515 Travoprost Extended Release (XR) in patients with Bilateral Ocular Hypertension or Pri…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-09-04Clinical Trial Update: A Multi-center, Randomized, Blinded Evaluator, Active Control, Parallel, Phase III Study to Evaluate the Efficacy and Safety of TJO-002 in POAG or Ocular Hypertension Patients [Phase 3]
Phase III clinical trial evaluating TJO-002 for primary open-angle glaucoma and ocular hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2019-08-07Clinical Trial Update: Study of SHP639 Eye Drops in Adults With High Eye Pressure or Primary Open-angle Glaucoma [Phase 1]
Phase 1 trial of SHP639 eye drops in adults with primary open-angle glaucoma or ocular hypertension has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-08-01Clinical Trial Update: Clinical Study of A Fixed Combination of Timolol-Brimonidine-Dorzolamide [Phase 2]
Phase 2 clinical trial of a fixed combination therapy (timolol-brimonidine-dorzolamide) for primary open-angle glaucoma and ocular hypertens…
-
CLINICAL_TRIALS trial_result · 2019-07-16Clinical Trial Update: Brinzolamide/Brimonidine Combination vs Brimonidine 0.2% in the Prevention of IOP Rise After Nd-YAG Laser Capsulotomy [Phase 4]
Phase 4 trial comparing brinzolamide/brimonidine combo to brimonidine alone for preventing intraocular pressure rise after Nd-YAG laser caps…
-
CLINICAL_TRIALS trial_result · 2019-06-11Clinical Trial Update: Study of Netarsudil Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) [Phase 2]
Phase 2 clinical trial of netarsudil ophthalmic solution in primary open angle glaucoma or ocular hypertension has completed with results po…
-
CLINICAL_TRIALS trial_result · 2019-06-04Clinical Trial Update: Double-masked Study of PG324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension [Phase 3]
A Phase 3 double-masked study of PG324 ophthalmic solution in open-angle glaucoma and ocular hypertension has completed, with results posted…
-
CLINICAL_TRIALS trial_result · 2019-06-04Clinical Trial Update: Study Assessing Safety and Efficacy of PG324 Ophthalmic Solution in Patients With Elevated Intraocular Pressure [Phase 2]
Phase 2 clinical trial evaluating safety and efficacy of PG324 ophthalmic solution for elevated intraocular pressure has been completed with…
-
CLINICAL_TRIALS trial_result · 2019-05-23Clinical Trial Update: Safety and Efficacy of Daily CF101 Administered Orally in Subjects With Elevated Intraocular Pressure [Phase 2]
Phase 2 trial assessing daily oral CF101 for safety and efficacy in subjects with elevated intraocular pressure; study completed with result…
-
CLINICAL_TRIALS trial_result · 2019-05-17Clinical Trial Update: Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV® [Phase 4]
Phase 4 trial update evaluating SIMBRINZA® as an adjunctive therapy to DUOTRAV® in open-angle glaucoma and ocular hypertension, terminated w…
-
CLINICAL_TRIALS trial_result · 2019-05-03Clinical Trial Update: Inhaled Corticosteroids: Effect on Intraocular Pressure in Patients With Controlled Glaucoma [Phase 4]
A Phase 4 trial evaluating the impact of inhaled corticosteroids on intraocular pressure in patients with controlled glaucoma, with complete…
-
CLINICAL_TRIALS trial_result · 2019-05-01Clinical Trial Update: Double-masked Study of PG324 Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension [Phase 3]
A Phase 3 double-masked trial evaluating PG324 Ophthalmic Solution in open-angle glaucoma and ocular hypertension has completed with results…
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product [Phase 2]
Open-label extension study assessing safety of ForSight VISION5 product in Phase 2 for glaucoma conditions; completed with results posted in…
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert [Phase 2]
Open-label extension to assess safety of the 13 mg bimatoprost ocular insert in patients with primary open-angle glaucoma or ocular hyperten…
-
CLINICAL_TRIALS trial_result · 2018-12-31Clinical Trial Update: A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular Hypertension [Phase 1, Phase 2]
Clinical trial evaluating a fixed combination ocular insert for open-angle glaucoma or ocular hypertension has completed phases 1 and 2 with…
-
CLINICAL_TRIALS trial_result · 2018-12-03Clinical Trial Update: A Clinical Study to Evaluate the Efficacy and Safety of CKD-351 [Phase 3]
Phase 3 trial evaluating CKD-351 for efficacy and safety in primary open-angle glaucoma and ocular hypertension.
-
CLINICAL_TRIALS trial_result · 2018-11-21Clinical Trial Update: Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial comparing BOL-303259-X ophthalmic solution to Timolol for open-angle glaucoma or ocular hypertension completed with results po…
-
CLINICAL_TRIALS trial_result · 2018-11-15Clinical Trial Update: SIMBRINZA® Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA) [Phase 4]
Phase 4 trial updating SIMBRINZA suspension as adjunctive therapy to prostaglandin analogues in open-angle glaucoma or ocular hypertension; …
-
CLINICAL_TRIALS trial_result · 2018-11-07Clinical Trial Update: Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial comparing BOL-303259-X with timolol in open-angle glaucoma or ocular hypertension has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-05Clinical Trial Update: Long-Term Non-Interventional Latanoprost Study
Long-term non-interventional trial of latanoprost completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-10-24Clinical Trial Update: Comparison of Combigan Two Times Daily (BID) Versus Simbrinza Three Times Daily (TID) [Phase 4]
A Phase 4 trial comparing Combigan BID to Simbrinza TID in glaucoma and ocular hypertension; results posted in 2018.